MAPK8 and autoimmune disease: The JNK-specific inhibitor CC-930 prevented dermal thickening, myofibroblast differentiation, and collagen accumulation in an animal model of systemic sclerosis, an autoimmune disorder that may also manifest with autoimmune arthritis [127].